Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(7 sites)
United States
Research Site, Birmingham, Alabama Research Site, Boston, Massachusetts Research Site, Cincinnati, Ohio Research Site, Portland, Oregon Research Site, Houston, Texas Spain
Research Site, Majadahonda